HomeProductsBioactive CompoundsMAPK/ERK PathwayRafDabrafenib Mesylate
Chemical structure of CAS 1195768-06-9

Dabrafenib Mesylate

CAS No.1195768-06-9
MDL No.MFCD20922872
MFC24H24F3N5O5S3
MW615.70
InChI KeyYKGMKSIHIVVYKY-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Dabrafenib mesylate is a methanesulfonate salt formed from equimolar amounts of dabrafenib and methanesulfonic acid. It is used in the treatment of metastatic melanoma and functions as an antineoplastic agent and B-Raf inhibitor.

CAS No.1195768-06-9
Product NameDabrafenib Mesylate

Biological Targets

BRAF

Associated Conditions

thyroid carcinoma·Erdheim-Chester disease·melanoma·glioma·multiple myeloma·
* The information provided here is compiled from public sources and is for reference only.

Documentation

Similar Products